BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 12008948)

  • 21. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of an effective fibrin beta-chain polymerization site: implications for the polymerization mechanism.
    Hsieh Kh
    Biochemistry; 1997 Aug; 36(31):9381-7. PubMed ID: 9235981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinogen and fibrin structure and functions.
    Mosesson MW
    J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.
    Spraggon G; Everse SJ; Doolittle RF
    Nature; 1997 Oct; 389(6650):455-62. PubMed ID: 9333233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-assembly of soluble unlinked and cross-linked fibrin oligomers.
    Rosenfeld MA; Leonova VB; Biryukova MI; Vasileva MV
    Biochemistry (Mosc); 2011 Oct; 76(10):1155-63. PubMed ID: 22098241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A molecular model of plasmic degradation of crosslinked fibrin.
    Francis CW; Marder VJ
    Semin Thromb Hemost; 1982 Jan; 8(1):25-35. PubMed ID: 6460319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular organization of copolymers of fibrinogen-fibrin fragment].
    Rozenfel'd MA; Gershkovich KB
    Mol Biol (Mosk); 1988; 22(4):923-33. PubMed ID: 3185535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
    Marchi RC; Carvajal Z; Boyer-Neumann C; Anglés-Cano E; Weisel JW
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin degradation products. A review of structures found in vitro and in vivo.
    Gaffney PJ
    Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early alpha chain crosslinking in human fibrin preparations.
    Sobel JH; Thibodeau CA; Canfield RE
    Thromb Haemost; 1988 Oct; 60(2):153-9. PubMed ID: 3217916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains.
    Siebenlist KR; Meh DA; Mosesson MW
    Biochemistry; 1996 Aug; 35(32):10448-53. PubMed ID: 8756701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble fibrin complexes: separation as a function of pH and characterization.
    Benabid Y; Concord E; Suscillon M
    Thromb Haemost; 1977 Feb; 37(1):144-53. PubMed ID: 14416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion.
    Redman CM; Xia H
    Ann N Y Acad Sci; 2001; 936():480-95. PubMed ID: 11460506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
    Dempfle CE; Argiriou S; Alesci S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
    Ann N Y Acad Sci; 2001; 936():210-4. PubMed ID: 11460476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
    McBane RD; Ford MA; Karnicki K; Stewart M; Owen WG
    Thromb Haemost; 2000 Jul; 84(1):83-7. PubMed ID: 10928475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.